RT info:eu-repo/semantics/bachelorThesis T1 Metamizol y riesgo de agranulocitosis A1 Vázquez Gómez, Laura K1 Metamizol, Agranulocitosis, Dipirona, Mecanismo de acción, Neutropenia, Seguridad, Interacciones farmacológicas. AB Metamizole or dipyrone is a drug that has been on the market for almost 100years and is used for successful analgesic and antipyretic treatment.Agranulocytosis is a very serious complication that can appear in patients afterthe administration of metamizole, during or after treatment.There is a great geographic variability in the incidence of agranulocytosis, beinghigher in some northern European countries if we compare it with southern andSouth American countries. The fact that more has been diagnosed in thesepatients has suggested a predisposing hereditary factor, which is why somestudies go in this direction.For this reason, there are many countries where its use is prohibited, otherswhere it is dispensed with a prescription and others where the sale is free. YR 2020 FD 2020 LK http://riull.ull.es/xmlui/handle/915/21693 UL http://riull.ull.es/xmlui/handle/915/21693 LA es DS Repositorio institucional de la Universidad de La Laguna RD 29-mar-2024